SERB receives EU approval for Voraxaze® (glucarpidase) as Rescue Therapy for High Dose Methotrexate…
London, Jan. 14, 2022 (GLOBE NEWSWIRE) -- SERB and BTG Specialty Pharmaceuticals today announced that the European Commission has granted marketing authorisation for Voraxaze® (glucarpidase) to reduce toxic plasma methotrexate…